- Otava collaborates with some of the largest pharmaceutical and biotechnology companies in the world as supplier of compounds for HTS, Building Blocks and Targeted Libraries:
-Actelion Pharmaceuticals Ltd (Switzerland)
-AstraZeneca Pharmaceuticals (UK)
-AstraZeneca R&D (Sweden)
-AstraZeneca R&D Montreal (Canada)
-Bayer Schering Pharma (Germany)
-Bayer CropScience GmbH (Germany)
-Boehringer Ingelheim GmbH (Austria)
-Campbell Family Institute for Breast Cancer Research, University Health Network (Canada)
-CARLOERBA-SDS (France)
-Chemfidence GmbH (Germany)
-Chem-Impex International Inc (USA)
-CV Therapeutics, Inc. (USA)
-Dana-Farber Cancer Institute - Harvard Medical School (USA)
-Dow AgroSciences (USA)
-Elan Pharmaceuticals (USA)
-Eli Lilly and Company (USA)
-EMD Biosciences, Inc. (USA)
-Galapagos (Belgium)
-Genentech, Inc. (USA)
-GlaxoSmithKline (UK)
-Grünenthal GmbH (Germany)
-LEO Pharma A/S (Denmark)
-Merck (USA)
-Merck KGaA (Germany)
-North Carolina State University (USA)
-Otsuka Maryland Medicinal Laboratories (USA)
-Pfizer (USA)
-Sanofi-Aventis (USA)
-Sanofi-Aventis Deutschland GmbH(Germany)
-Schering Corporation(USA)
-Sigma Aldrich (France)
-Sigma-Aldrich (USA)
-Solvay Pharmaceuticals GmbH (Germany)
-Summit Pharmaceuticals International Corporation (Japan)
-SuperGen, Inc (USA)
-Syngenta (UK)
-Takeda Cambridge Limited (UK)
-UCB Pharma SA (Belgium)
-Vertex Pharmaceuticals LLC (USA)
-Wako Pure Chemical Industries, Ltd. (Japan)
|